OS Therapies Inc (OSTX) SEC Filings & Financial Intelligence
OS Therapies Inc (OSTX) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OSTX
CIK: 1795091
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MaloneBailey, LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerMariano Frugone
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114611 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114610 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114609 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114608 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114607 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114606 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114605 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114604 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-22 | 4 Filing | 0001213900-26-114603 | View SEC Doc Filr Page |
| D | 2026-10-23 | — | D Filing | 0000921895-26-002846 | View SEC Doc Filr Page |
| 8-K | 2026-10-19 | 2026-10-15 | CURRENT REPORT | 0001213900-26-110497 | View SEC Doc Filr Page |
| 3 | 2026-10-05 | 2026-09-29 | 3 Filing | 0001213900-26-106858 | View SEC Doc Filr Page |
| 3 | 2026-10-05 | 2026-09-29 | 3 Filing | 0001213900-26-106857 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-09-29 | CURRENT REPORT | 0001213900-26-106849 | View SEC Doc Filr Page |
| S-8 | 2026-09-21 | — | REGISTRATION STATEMENT | 0001213900-26-101526 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | CURRENT REPORT | 0001213900-26-098880 | View SEC Doc Filr Page |
| 424B7 | 2026-09-10 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-098870 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | CURRENT REPORT | 0001213900-26-098403 | View SEC Doc Filr Page |
| D | 2026-08-25 | — | D Filing | 0000921895-26-002306 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-21 | CURRENT REPORT | 0001213900-26-092651 | View SEC Doc Filr Page |
| 424B5 | 2026-08-21 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-092627 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090238 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-06 | CURRENT REPORT | 0001213900-26-088435 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-07-31 | CURRENT REPORT | 0001213900-26-086150 | View SEC Doc Filr Page |
| 424B5 | 2026-08-06 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-086149 | View SEC Doc Filr Page |